About Minnetronix Medical
Minnetronix Medical is a company based in Saint Paul (United States) founded in 1996 was acquired by Altaris in February 2021. Minnetronix Medical has raised $20 million across 11 funding rounds from investors including NIH, HHS and Altaris. The company has 263 employees as of December 31, 2020. Minnetronix Medical has completed 1 acquisition, including Neurofluidics. Minnetronix Medical offers products and services including Full Lifecycle Solutions, Optical Systems, RF Energy, Electroporation, and Stimulation and Active Wearables. Minnetronix Medical operates in a competitive market with competitors including Blackrock Neurotech, Nexstim, MindMaze, Precision Neuroscience and Synergia Medical, among others.
- Headquarter Saint Paul, United States
- Employees 263 as on 31 Dec, 2020
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Minnetronix, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Minnetronix Medical
Minnetronix Medical offers a comprehensive portfolio of products and services, including Full Lifecycle Solutions, Optical Systems, RF Energy, Electroporation, and Stimulation and Active Wearables.
Offers design, development, and manufacturing for medical devices
Develops optical technologies for healthcare applications
Provides RF energy solutions for medical device innovation
Handles electroporation techniques for therapeutic uses
Engineers wearable devices for medical stimulation
People of Minnetronix Medical
Unlock access to complete
Funding Insights of Minnetronix Medical
Minnetronix Medical has successfully raised a total of $20M across 11 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Minnetronix Medical
Minnetronix Medical has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, HHS and Altaris.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
PE firm invests in the US
|
Locked | Locked | Locked | |
|
Drug discovery services are provided to the biopharma sector.
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for Minnetronix Medical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Minnetronix Medical
Minnetronix Medical has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Neurofluidics.
Investment portfolio details for Minnetronix Medical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Develops devices for the treatment of neurological disorders
|
Locked | Locked | 2007 | Locked |
Complete acquisition details for Minnetronix Medical
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Minnetronix Medical
Detailed financials for Minnetronix Medical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Minnetronix Medical Comparisons
Peer comparison for Minnetronix Medical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Minnetronix Medical
Minnetronix Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Blackrock Neurotech, Nexstim, MindMaze, Precision Neuroscience and Synergia Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Medical devices for neurological therapies are developed.
|
|
| Locked | Locked | Locked |
Noninvasive brain stimulation is provided for stroke patient rehabilitation.
|
|
| Locked | Locked | Locked |
Evidence-based digital neurotherapeutics are developed for brain health recovery.
|
|
| Locked | Locked | Locked |
Brain-computer interfaces developed for medical treatment and drug development.
|
|
| Locked | Locked | Locked |
Implantable neurostimulators and contactless monitoring systems are developed.
|
|
| Locked | Locked | Locked |
Bioelectronic devices are developed for regenerative medicine therapies.
|
Detailed competitors of Minnetronix Medical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Minnetronix Medical
Complete news archive for Minnetronix Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Minnetronix Medical
Minnetronix Medical was founded in 1996 and raised its 1st funding round 15 years after it was founded.
Minnetronix Medical is headquartered in Saint Paul, United States. It is registered at Saint Paul, Minnesota, United States.
Rich Nazarian is the current CEO of Minnetronix Medical.
Minnetronix Medical is a funded company, having raised a total of $20M across 11 funding rounds to date.
As of Dec 31, 2020, the latest employee count at Minnetronix Medical is 263.
Manufacturer of multiple devices for neurocritical patients. The products provided are spinal cord stimulation devices for chronic pain, urinary incontinence, muscle stimulation, peripheral nerve, intracranial stimulation, and others. It also provides endoscopic imaging systems and test equipment. The company is developing a portfolio of solutions designed to prevent secondary injury and enhance healing for patients. It also developed optical systems that create algorithms for image processing and display to optimize sensor performance and visualization. It provides thermal simulation and modeling techniques that help in electroporation and trans-cellular pharmaceutical delivery. The platform offers neurapheresis therapies for the treatment and return of cerebrospinal fluid.
Minnetronix Medical's top competitors include Blackrock Neurotech, Precision Neuroscience and Nexstim.
Minnetronix Medical offers Full Lifecycle Solutions, Optical Systems, RF Energy, Electroporation, and Stimulation and Active Wearables.
Minnetronix Medical has made 1 acquisition, including Neurofluidics.